## Consolidated Statement of Cash Flows

**Year Ended** *(In thousands, except shares and per share data)*

|  | Dec 31, 2011 | Dec 31, 2010 | Dec 31, 2009 |
| --- | --- | --- | --- |
| **      Cash Flows From Operating Activities** |  |  |  |
|         Net Income | $(254,411) | $(154,328) | $(55,740) |
| *          Accumulated Deficit* | $(254,411) | $(154,328) | $(55,740) |
| **        Adjustments to reconcile net loss to net cash used in operating activities:** |  |  |  |
|           Depreciation and Amortization | $16,919 | $10,623 | $6,940 |
|           Change in fair value of warrant liabilities | $2,750 | $5,022 | $1,128 |
|           Gain on extinguishment of convertible notes and warrants |  |  | $(1,468) |
|           Discounts and premiums on short-term marketable securities | $(112) |  |  |
|           Stock-based compensation | $29,419 | $21,156 | $1,434 |
|           Excess tax benefits from stock-based compensation |  | $(74) |  |
|           Loss on abandonment of fixed assets | $345 | $8 | $385 |
|           Inventory write-downs | $1,828 | $951 | $1,353 |
|           Interest on convertible notes |  |  | $2,686 |
| **        Changes in operating assets and liabilities** |  |  |  |
|           Accounts receivable | $(2,829) | $(3,222) | $(168) |
|           Inventories and operating lease vehicles | $(13,638) | $(28,513) | $(7,925) |
|           Prepaid expenses and other current assets | $(248) | $(4,977) | $(2,042) |
|           Other assets | $(288) | $(463) | $(445) |
|           Accounts payable | $31,859 | $(212) | $902 |
|           Accrued liabilities | $12,321 | $13,345 | $3,387 |
|           Deferred development compensation |  | $(156) | $(10,017) |
|           Deferred revenue | $(1,927) | $4,801 | $(1,456) |
|           Reservation payments | $61,006 | $4,707 | $(21,971) |
|           Other long-term liabilities | $2,641 | $3,515 | $2,192 |
|         Net Cash from Operating Activities | $(114,364) | $(127,817) | $(80,825) |
| **      Cash Flows From Investing Activities** |  |  |  |
|         Purchases of marketable securities | $(64,952) |  |  |
|         Proceeds from Maturities, Prepayments and Calls of Securities | $40,000 |  |  |
|         Payments related to acquisition of Fremont manufacturing facility and related assets |  | $(65,210) |  |
|         Payments for Property, Plant and Equipment | $(197,896) | $(40,203) | $(11,884) |
|         Withdrawals out of (transfers into) our dedicated Department of Energy account, net | $50,121 | $(73,597) |  |
|         Increase in other restricted cash | $(3,201) | $(1,287) | $(2,360) |
|         Net Cash from Investing Activities | $(175,928) | $(180,297) | $(14,244) |
| **      Cash Flows From Financing Activities** |  |  |  |
|         Proceeds from issuance of common stock in public offerings | $172,410 | $188,842 |  |
|         Proceeds from issuance of common stock in private placements | $59,058 | $80,000 |  |
|         Proceeds from issuance of convertible preferred stock |  |  |  |
| *          Series F Convertible Preferred Stock* |  |  | $82,378 |
| *          Series E Convertible Preferred Stock* |  |  | $49,444 |
|         Principal payments on capital leases and other debt | $(416) | $(315) | $(322) |
|         Proceeds from Issuance of Long-Term Debt | $204,423 | $71,828 |  |
|         Proceeds from issuance of convertible notes and warrants |  |  | $25,468 |
|         Proceeds from exercise of stock options and other stock issuances | $10,525 | $1,350 | $497 |
|         Excess tax benefits from stock-based compensation |  | $74 |  |
|         Deferred common stock and loan facility issuance costs |  | $(3,734) | $(2,046) |
|         Net Cash from Financing Activities | $446,000 | $338,045 | $155,419 |
|       Net Change in Cash | $155,708 | $29,931 | $60,350 |
|       Cash and Cash Equivalents |  |  |  |
|       Cash and Cash Equivalents |  |  |  |
| **      Supplemental Disclosures** |  |  |  |
|         Interest paid | $3,472 | $1,138 | $70 |
|         Income taxes paid | $282 | $9 | $171 |
| **      Supplemental noncash investing and financing activities** |  |  |  |
|         Conversion of preferred stock to common stock |  | $319,225 |  |
|         Issuance of common stock upon net exercise of warrants |  | $6,962 |  |
|         Issuance of convertible preferred stock warrant |  | $6,294 |  |
|         Issuance of common stock warrant |  | $1,701 |  |
|         Conversion of notes payable to Series E convertible preferred stock |  |  | $86,225 |
|         Exchange of convertible notes payable |  |  | $19,073 |
|         Exchange of accrued interest for convertible notes payable |  |  | $1,791 |
|         Acquisition of property and equipment | $2,703 | $4,482 | $183 |